Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
07/03/2003 | US20030125320 Seratonin reuptake inhibitors potently binding to the 5-HT1A receptor, dopaminergic agents; antidepressants, psychosis, anxiolytic and antiischemic agents; panic order; obsessive compulsive disorder, impulse control disorder, alcohol abuse |
07/03/2003 | CA2473862A1 Pyridoquinoxaline antivirals |
07/03/2003 | CA2471089A1 Pyridoquinoxaline antivirals |
07/03/2003 | CA2471085A1 Aroyl pyridinones |
07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
07/02/2003 | EP1323711A1 Novel phenylalanine derivatives |
07/02/2003 | EP1323710A1 Nitrogenous five-membered ring compounds |
07/02/2003 | EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
07/02/2003 | EP1323429A1 Preventives/remedies for emotional disorders |
07/02/2003 | EP1322710A1 Modified carbocyanine dyes and their conjugates |
07/02/2003 | EP1322651A1 Bicyclic heteroaromatic compounds |
07/02/2003 | EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
07/02/2003 | EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
07/02/2003 | EP1322638A1 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition |
07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
07/02/2003 | EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
07/02/2003 | EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
07/02/2003 | EP1322611A1 Chemical compounds |
07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
07/02/2003 | EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents |
07/02/2003 | EP1322161A1 Use of riboflavin and flavin derivatives as chitinase inhibitors |
07/02/2003 | EP1210346B1 New active marine alkaloids |
07/02/2003 | EP1053237B1 Inhibition of human telomerase by a g-quadruplex-interaction compound |
07/02/2003 | EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity |
07/02/2003 | CN1427827A 2-Hydroxy-mutilin carbamate derivatives for antibacterial use |
07/02/2003 | CN1427721A Peptide deformylase inhibitors |
07/02/2003 | CN1113064C Cis-substituted aminocyclopropane derivatives |
07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
07/02/2003 | CN1112928C Use of CGMP-phosphodiesterase inhibitors to treat impotence |
07/01/2003 | US6586604 Tricyclic amine derivatives |
07/01/2003 | US6586596 Acetylcholine enhancers |
07/01/2003 | US6586595 For treatment of Parkinson's Disease |
07/01/2003 | US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies |
07/01/2003 | US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea |
07/01/2003 | US6586435 Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
07/01/2003 | US6586418 Heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes; anticoagulant for treatment and prevention of thromboembolic disorders |
06/26/2003 | WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof |
06/26/2003 | WO2003051880A1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
06/26/2003 | WO2003051879A1 Known and novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones useful as poly(adp-ribose)polymerase inhibitors |
06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
06/26/2003 | WO2003051877A1 2-substituted pyrrolo[2.1-a]isoquinolines against cancer |
06/26/2003 | WO2003051876A1 Pyrazolopyridine derivatives and medicinal use thereof |
06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
06/26/2003 | WO2003051838A2 Protein kinase inhibitors |
06/26/2003 | WO2003051458A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
06/26/2003 | WO2003051366A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
06/26/2003 | WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof |
06/26/2003 | US20030120072 Such as (4-(3,4-Difluoro-phenyl)-piperazin-1-yl)-((4S ,4aS,8aR)-2-((S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl)-decahydro -isoquinolin-4yl)-methanone for treatment of schizophrenia, depression, anxiety and bipolar disorders |
06/26/2003 | US20030120068 Reacting 2-amino-3-hydroxymethyl or 3-halomethyl pyridine with N-methyl-1-phenyl-2,2'-iminodiethyl halogen to form 1-(3-hydroxy methylpyridyl-2)-4-methyl-2-phenyl-piperazine, and adding a ring closing reagent |
06/26/2003 | US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis |
06/26/2003 | US20030119868 Gyrase inhibitors and uses thereof |
06/26/2003 | US20030119861 Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines |
06/26/2003 | US20030119848 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
06/26/2003 | US20030119843 Tricycloheteroaromic ring containing imidazole compounds used as farnesyl transferase and geranylgeranyl transferase inhibitor |
06/26/2003 | US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
06/26/2003 | US20030119840 4-Heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof |
06/26/2003 | US20030119839 Indalones and other fused heterocylce-ones |
06/26/2003 | US20030119837 Pharmaceutical composition for the treatment of CNS and other disorders |
06/26/2003 | US20030119834 Angiogenesis inhibitors; 3-alkyl-4-one quinazoline derivatives |
06/26/2003 | US20030119823 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids |
06/26/2003 | US20030119822 Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists |
06/26/2003 | US20030119813 Inhibitors of phosphodiesterase (PDE) isoenzymes; bronchodilators with anti-inflammatory properties. |
06/26/2003 | US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke. |
06/26/2003 | US20030119793 CAK inhibitors and uses thereof |
06/26/2003 | US20030119085 Substrates for beta-lactamase and uses thereof |
06/26/2003 | US20030119040 Universal nucleotides for nucleic acid analysis |
06/26/2003 | US20030118877 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators |
06/26/2003 | CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives |
06/26/2003 | CA2470307A1 Protein kinase inhibitors |
06/26/2003 | CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
06/26/2003 | CA2469048A1 Quinolinones as prostaglandin receptor ligands |
06/26/2003 | CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof |
06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/25/2003 | EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
06/25/2003 | EP1320530A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
06/25/2003 | EP1320529A1 Quinoline derivatives as antibacterials |
06/25/2003 | EP1320528A2 Substituted phthalides as anti-convulsive drugs |
06/25/2003 | EP1098896B1 5-bicycloindole compounds |
06/25/2003 | EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
06/25/2003 | EP0641343B1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
06/25/2003 | CN1426414A Prodrugs of imidazopyridine derivatives |
06/25/2003 | CN1426413A Imidazopyridine derivatives |
06/25/2003 | CN1426412A Novel compounds |
06/25/2003 | CN1426410A Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof |
06/25/2003 | CN1426405A 新型环状酰胺衍生物 Novel cyclic amide derivative |
06/25/2003 | CN1426395A Inhibitors of dipeptidyl peptidase IV |
06/25/2003 | CN1426394A Novel compounds |
06/25/2003 | CN1426393A Novel compounds |
06/25/2003 | CN1112365C Piperidine derivatives and preparing method and use |
06/24/2003 | US6583319 Cyclic compounds having a cycloalkylene chain |
06/24/2003 | US6583307 Convenient and efficient Suzuki-Miyaura cross-coupling catalyzed by a palladium/diazabutadiene system |
06/24/2003 | US6583285 One step reaction of such as 3-(4-methyl-benzoyl)-2-bromo-propyl-dimethylamide and 6-amino-3-picoline |
06/24/2003 | US6583154 Compounds and methods which modulate feeding behavior and related diseases |
06/24/2003 | US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone |
06/24/2003 | US6583150 Cytotoxic propertie; antitumor; pyrido-(3,2-g)quinoline-5,10-diones; benzo(b)pyrido(4,3,2-de)(1,7)-phenanthroline-8-ones |
06/24/2003 | US6583143 CRF receptor antagonists and methods relating thereto |